Evecxia Therapeutics

Hormones in the brain concept
#Antidepressants #Depression #Evecxia Therapeutics #Major depressive disorder #Phase I trial #Psychiatry

New adjunctive antidepressant elevates serotonin in Phase I trial

Evecxia Therapeutics has reported favourable safety, tolerability, pharmacokinetic, and pharmacodynamic data from a Phase I trial of EVX-101 in healthy volunteers treated with escitalopram. The company is also planning a Phase II adjunctive EVX-101 trial in patients with major depressive disorder (MDD) responding inadequately to a… Read More

#News